Stefan Sleijfer

Active 2001–2025

130
Papers
21,597
Citations
80
h-index
127
i10-index

Citations

Citations per year for Stefan Sleijfer1926: 3 citations1993: 1 citations2000: 2 citations2002: 1 citations2003: 2 citations2004: 1 citations2005: 8 citations2006: 7 citations2007: 12 citations2008: 35 citations2009: 55 citations2010: 116 citations2011: 137 citations2012: 136 citations2013: 190 citations2014: 153 citations2015: 174 citations2016: 198 citations2017: 186 citations2018: 203 citations2019: 738 citations2020: 907 citations2021: 1,033 citations2022: 827 citations2023: 633 citations2024: 989 citations2025: 375 citations2026: 14 citations1927–1992: no citations, so these years are not shown1994–1999: no citations, so these years are not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,203 citing papers, 21.3% of this breakdownChina: 986 citing papers, 9.5% of this breakdownGermany: 690 citing papers, 6.7% of this breakdownNetherlands: 690 citing papers, 6.7% of this breakdownUnited Kingdom: 659 citing papers, 6.4% of this breakdownItaly: 638 citing papers, 6.2% of this breakdownFrance: 541 citing papers, 5.2% of this breakdownSpain: 346 citing papers, 3.4% of this breakdownCanada: 285 citing papers, 2.8% of this breakdownJapan: 242 citing papers, 2.3% of this breakdownAustralia: 241 citing papers, 2.3% of this breakdownBelgium: 218 citing papers, 2.1% of this breakdown
0%21.3%Other 25.1%

Fields

  • Medicine68.6%
  • Biochemistry, Genetics and Molecular Biology24.4%
  • Immunology and Microbiology3.1%
  • Engineering1.6%
  • Computer Science0.5%
  • Materials Science0.3%
  • Other1.5%

Topics

  • Cancer Genomics and Diagnostics6.4%
  • CAR-T cell therapy research5.4%
  • Sarcoma Diagnosis and Treatment5%
  • Cancer Cells and Metastasis4.1%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Immunotherapy and Immune Responses2.2%
  • Other74%

Coauthors

All papers

Open in search
  1. Pan-cancer whole-genome analyses of metastatic solid tumours

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 1,213

  2. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 989

  3. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 1,621

  4. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Gronchi, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, A. López Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Ruth Ladenstein, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 455

  5. Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

    Authors: , , , , , , , , , , - Molecular Therapy 2013 cited by 709

  6. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Alessandro Gronchi, Silvia Stacchiotti - Annals of Oncology 2021 cited by 563

  7. Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

    Authors: , , , , , , , , - Journal of Clinical Oncology 2006 cited by 911

  8. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 269

  9. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 751

  10. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 641

  11. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel - JNCI Journal of the National Cancer Institute 2018 cited by 282

  12. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2019 cited by 333

  13. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 209

  14. Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab

    Authors: , , , , , , , , - The Lancet Oncology 2022 cited by 90

  15. Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells–a completed study overview

    Authors: , , , , - Biochemical Society Transactions 2016 cited by 179

  16. TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Sleijfer, Anders Ullén, Jeffrey Yachnin, Henrik Grönberg, Steven Van Laere, Johan Lindberg, Luc Dirix - Clinical Cancer Research 2018 cited by 171

  17. Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells

    Authors: , , , , , , , , , - Blood 2010 cited by 367

  18. 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up

    Authors: , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2018 cited by 143

  19. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

    Authors: , , , , , , , , , , , - Nature Communications 2021 cited by 124

  20. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2021 cited by 92

  21. Side Effects of Interferon-α Therapy

    Authors: , , , , - Pharmacy World & Science 2005 cited by 285

  22. Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 681

  23. The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature

    Authors: , , , , - The Oncologist 2016 cited by 224

  24. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy

    Authors: , , , , , - The Breast 2016 cited by 146